MXPA04001201A - Derivados tetraciclicos de indol como ligandos del receptor de 5-ht. - Google Patents

Derivados tetraciclicos de indol como ligandos del receptor de 5-ht.

Info

Publication number
MXPA04001201A
MXPA04001201A MXPA04001201A MXPA04001201A MXPA04001201A MX PA04001201 A MXPA04001201 A MX PA04001201A MX PA04001201 A MXPA04001201 A MX PA04001201A MX PA04001201 A MXPA04001201 A MX PA04001201A MX PA04001201 A MXPA04001201 A MX PA04001201A
Authority
MX
Mexico
Prior art keywords
receptor ligands
indole derivatives
tetracyclic indole
compounds
formula
Prior art date
Application number
MXPA04001201A
Other languages
English (en)
Inventor
D Ennis Michael
Original Assignee
Pharmacia & Up John Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Up John Company filed Critical Pharmacia & Up John Company
Publication of MXPA04001201A publication Critical patent/MXPA04001201A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente invencion proporciona compuestos de formula (I), en donde R1, R2, R3, R4, Y, b, y c tienen cualquiera de los valores definidos en la especificacion, asi como composiciones farmaceuticas que comprenden los compuestos. La invencion tambien proporciona metodos terapeuticos para el tratamiento de enfermedades en donde la modulacion de la actividad 5-HT se desea, asi como un procedimiento e intermediarios utiles para la preparacion de compuestos de formula I.
MXPA04001201A 2001-08-06 2002-08-05 Derivados tetraciclicos de indol como ligandos del receptor de 5-ht. MXPA04001201A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31033201P 2001-08-06 2001-08-06
PCT/US2002/025073 WO2003028733A1 (en) 2001-08-06 2002-08-05 Tetracyclic indole derivatives as 5-ht receptor ligands

Publications (1)

Publication Number Publication Date
MXPA04001201A true MXPA04001201A (es) 2004-05-20

Family

ID=23202032

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001201A MXPA04001201A (es) 2001-08-06 2002-08-05 Derivados tetraciclicos de indol como ligandos del receptor de 5-ht.

Country Status (7)

Country Link
US (1) US20030060462A1 (es)
EP (1) EP1423123A1 (es)
JP (1) JP2005504114A (es)
BR (1) BR0211562A (es)
CA (1) CA2453343A1 (es)
MX (1) MXPA04001201A (es)
WO (1) WO2003028733A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6994384B2 (en) * 2002-11-20 2006-02-07 General Electric Company Integrated solitary bumper beam
EP2248524A3 (en) 2004-08-25 2011-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
EP2789338A3 (en) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Condensed pyridine derivate and use thereof
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
EP2516396A1 (en) 2009-12-23 2012-10-31 Wayne State University Therapeutic compounds
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314900A (en) * 1992-11-19 1994-05-24 Merck Frosst Canada, Inc. Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene biosynthesis
AR023574A1 (es) * 1999-04-23 2002-09-04 Pharmacia & Upjohn Co Llc Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
IL145998A0 (en) * 1999-06-15 2002-07-25 Du Pont Pharm Co Substituted heterocycle fused gamma-carbolines
AU2001269781A1 (en) * 2000-07-06 2002-01-21 Pharmacia And Upjohn Company Substituted 2,3,7,8,9,10,11,12-octahydroazepino(4,5-b)pyrano(3,2-e) indoles

Also Published As

Publication number Publication date
CA2453343A1 (en) 2003-04-10
JP2005504114A (ja) 2005-02-10
US20030060462A1 (en) 2003-03-27
EP1423123A1 (en) 2004-06-02
WO2003028733A1 (en) 2003-04-10
BR0211562A (pt) 2004-07-13

Similar Documents

Publication Publication Date Title
MXPA04001203A (es) 1-h-pirido[4,3-b] indoles terapeuticos.
MXPA04007470A (es) Piridinonas sustituidas.
TW200517109A (en) Substituted pyridinones
WO2001017963A3 (en) Aminoalkoxy carbazoles and their use as 5-ht ligands
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
WO2004087677A3 (en) Pyrimidin-4-one derivatives and their use as p38 kinase modulators
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
IL175819A0 (en) Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
MXPA05009359A (es) Tetrahidroisoquinolinas 2,5- y 2,6 substituidas para uso como moduladores 5-ht6.
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
MXPA04003594A (es) Azaindoles e indolinas tetraciclicas que tienen actividad en serotonina 5-ht-2.
DE60001586D1 (de) Diphenyl-piperidin derivate
WO2003024976A3 (en) Tricyclic indole derivatives as 5-ht ligands
MXPA04000358A (es) Hexahidroazepino (4,5-g) indoles e indolinas como ligandos del receptor 5-ht.
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
ATE384708T1 (de) Piperazinderivate als aktivitätsmodulatoren der chemokinrezeptoren
MXPA04001201A (es) Derivados tetraciclicos de indol como ligandos del receptor de 5-ht.
MXPA04000036A (es) Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht.
ATE517626T1 (de) Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
WO2003045940A3 (en) Benzazepine derivatives and their use as 5-ht ligands
WO2003076426A3 (en) Pyridinyloxy derivatives as 5-ht receptor ligands
MXPA06000892A (es) Compuestos azapoliciclicos arilo fusionados.
UA81405C2 (en) Substituted pyridinones as modulators of p38 map kinase
SG153727A1 (en) Substituted pyridinones as modulators of p38 map kinase